Literature DB >> 20840438

Testing new drugs in naked apes and getting the dose right in their young.

James M Ritter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20840438      PMCID: PMC2950981          DOI: 10.1111/j.1365-2125.2010.03782.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  13 in total

1.  What is the right dose for children?

Authors:  Massimo Cella; Catherijne Knibbe; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2010-10       Impact factor: 4.335

2.  Introduction to tripartite meeting report (convenors: Dr Nigel Baber and Prof. Ros Smyth): towards establishing optimal doses for drugs prescribed to children.

Authors:  N S Baber; R Smyth
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

Review 3.  Tripartite meeting. Paediatric regulatory guidelines: do they help in optimizing dose selection for children?

Authors:  N S Baber
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

Review 4.  Better medicines for children--where are we now, and where do we want to be?

Authors:  Klaus Rose
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

5.  Should we tolerate tolerability as an objective in early drug development?

Authors:  A Cohen
Journal:  Br J Clin Pharmacol       Date:  2007-09       Impact factor: 4.335

6.  Proposals for model-based paediatric medicinal development within the current European Union regulatory framework.

Authors:  Efthymios Manolis; Gérard Pons
Journal:  Br J Clin Pharmacol       Date:  2009-10       Impact factor: 4.335

7.  Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene.

Authors:  K L Mealey; S A Bentjen; J M Gay; G H Cantor
Journal:  Pharmacogenetics       Date:  2001-11

Review 8.  Information about adverse drug reactions reported in children: a qualitative review of empirical studies.

Authors:  Lise Aagaard; Arne Christensen; Ebba Holme Hansen
Journal:  Br J Clin Pharmacol       Date:  2010-10       Impact factor: 4.335

Review 9.  Modelling approaches to dose estimation in children.

Authors:  Trevor N Johnson
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

10.  Breed distribution and history of canine mdr1-1Delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage.

Authors:  Mark W Neff; Kathryn R Robertson; Aaron K Wong; Noa Safra; Karl W Broman; Montgomery Slatkin; Katrina L Mealey; Niels C Pedersen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

View more
  2 in total

1.  Exploiting modern cannabinoid pharmacology for therapeutic gain?

Authors:  James M Ritter
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

2.  More on first-in-man studies.

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.